Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Related Concept Videos

Statistical Methods to Analyze Parametric Data: ANOVA01:12

Statistical Methods to Analyze Parametric Data: ANOVA

Analysis of Variance, or ANOVA, is a powerful statistical technique used to analyze parametric data, primarily in research and experimental studies. It's designed to compare the means of two or more groups, assisting researchers in identifying any significant differences between these group means. There are two main types of ANOVA based on the complexity of the analysis: one-way and two-way.
One-way ANOVA is applied when a single independent variable or factor is scrutinized. It compares the...
Statistical Analysis: Overview01:11

Statistical Analysis: Overview

When we take repeated measurements on the same or replicated samples, we will observe inconsistencies in the magnitude. These inconsistencies are called errors. To categorize and characterize these results and their errors, the researcher can use statistical analysis to determine the quality of the measurements and/or suitability of the methods.
One of the most commonly used statistical quantifiers is the mean, which is the ratio between the sum of the numerical values of all results and the...
What is an ANOVA?01:16

What is an ANOVA?

The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples should be randomly and...
What is ANOVA?01:13

What is ANOVA?

The Analysis of Variance or ANOVA is a statistical test developed by Ronald Fisher in 1918. It is performed on three or more samples to check for equality between their means.
Before performing ANOVA, one must ensure that the samples used for this analysis have three crucial characteristics or statistical assumptions. The first assumption states that the samples should be drawn from normally distributed samples, while the second requires that all the drawn samples be randomly and independently...
Mechanistic Models: Compartment Models in Individual and Population Analysis01:23

Mechanistic Models: Compartment Models in Individual and Population Analysis

Mechanistic models are utilized in individual analysis using single-source data, but imperfections arise due to data collection errors, preventing perfect prediction of observed data. The mathematical equation involves known values (Xi), observed concentrations (Ci), measurement errors (εi), model parameters (ϕj), and the related function (ƒi) for i number of values. Different least-squares metrics quantify differences between predicted and observed values. The ordinary least squares (OLS)...
Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis00:59

Model-Independent Approaches for Pharmacokinetic Data: Noncompartmental Analysis

Noncompartmental analyses offer an alternative method for describing drug pharmacokinetics without relying on a specific compartmental model. In this approach, the drug's pharmacokinetics are assumed to be linear, with the terminal phase log-linear. This assumption allows for simplified analysis and interpretation of the drug's behavior in the body.
One important characteristic of noncompartmental analyses is that drug exposure increases proportionally with increasing doses. This relationship...

You might also read

Related Articles

Articles linked to this work by shared authors, journal, and citation graph.

Sort by
Same author

Association between comorbidities and major adverse cardiovascular events in patients undergoing immune checkpoint blockade.

BMC cancer·2026
Same author

Acceptance and preferences for different nicotine substitute products to reduce tobacco smoking in people living with HIV: Results from an internal pilot study of a randomized trial.

Tobacco induced diseases·2026
Same author

Validation of photoplethysmography-derived short-term heart rate variability using a wearable device.

Scientific reports·2026
Same author

Linezolid in addition to standard antibiotic treatment for <i>Staphylococcus aureus</i> bacteraemia: study protocol for a randomised, placebo-controlled trial.

BMJ open·2026
Same author

Offer of a menu of different nicotine substitute products to REduce Tobacco Use iN pEople living with HIV (RETUNE): a protocol for a pragmatic randomized trial within the Swiss HIV Cohort Study.

Trials·2026
Same author

Barriers and Facilitators of Platform Trials.

JAMA network open·2026
Same journal

Metamizole-induced agranulocytosis: utilisation trends, pharmacovigilance signals and regulatory risk-minimisation in Switzerland.

Swiss medical weekly·2026
Same journal

Female genital mutilation/cutting and risk of obstetric anal sphincter injury at delivery.

Swiss medical weekly·2026
Same journal

Drug prescription before and after implementation of a CPOE system on the Paediatric Intensive Care Unit: a quality improvement study.

Swiss medical weekly·2026
Same journal

Trends in health- and lifestyle-related aspects in women of childbearing age: analysis of Swiss Health Survey data between 1992 and 2022.

Swiss medical weekly·2026
Same journal

Microplastics in the air and potential health risks - a narrative review.

Swiss medical weekly·2026
Same journal

Potentially inappropriate medication: prevalence, risk of hospitalisation and associated healthcare costs in the general older population of Switzerland.

Swiss medical weekly·2026
See all related articles

Related Experiment Video

Updated: May 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)

Published on: November 27, 2019

Meta-analyses: what they can and cannot do.

Alain J Nordmann1, Benjamin Kasenda, Matthias Briel

  • 1Basel Institute for Clinical Epidemiology and Biostatistics, University Hospital Basel, Switzerland.

Swiss Medical Weekly
|March 13, 2012
PubMed
Summary
This summary is machine-generated.

Meta-analyses combine individual study results to provide a reliable estimate of treatment effects. Rigorous systematic reviews ensure meta-analyses are powerful tools for evidence-based clinical and health policy decisions.

More Related Videos

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Related Experiment Videos

Last Updated: May 24, 2026

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)
06:26

Meta-analysis of Voxel-Based Neuroimaging Studies using Seed-based d Mapping with Permutation of Subject Images (SDM-PSI)

Published on: November 27, 2019

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials
08:36

The Adjuvant Efficacy of Angong Niuhuang Pill in the Treatment of Viral Encephalitis: A Meta-Analysis of Randomized Controlled Trials

Published on: April 19, 2024

Area of Science:

  • Medical Research Methodology
  • Evidence Synthesis
  • Clinical Epidemiology

Background:

  • Individual studies often have small sample sizes or focus on rare outcomes, limiting definitive conclusions.
  • Conflicting or inconclusive results from randomized controlled trials necessitate a method to synthesize evidence.
  • Meta-analysis addresses these limitations by pooling data to generate a robust estimate of treatment benefit or harm.

Purpose of the Study:

  • To highlight the importance and methodology of meta-analysis within systematic reviews.
  • To discuss various types of meta-analysis, including cumulative, individual patient data, and network meta-analysis.
  • To emphasize the role of meta-analysis in evidence-based decision-making.

Main Methods:

  • Conducting comprehensive and reproducible searches for primary studies.
  • Applying clear eligibility criteria for study selection.
  • Performing standardized critical appraisal of included studies for quality assessment.
  • Investigating heterogeneity among studies.

Main Results:

  • Meta-analyses, when free of bias and heterogeneity, reliably demonstrate intervention effects.
  • Cumulative meta-analysis can expedite the adoption of effective treatments and early detection of adverse effects.
  • Individual patient data meta-analyses allow for subgroup analysis and standardized criteria application.
  • Network meta-analysis integrates direct and indirect comparisons to evaluate multiple treatments.

Conclusions:

  • Meta-analysis is a versatile and powerful tool in medical research.
  • When performed rigorously within a systematic review, meta-analysis is crucial for evidence-based practice and health policy.
  • It enables reliable demonstration of treatment benefits or harms, especially when individual trial results are conflicting.